NCT00457340View on ClinicalTrials.gov

Atorvastatin For The Reduction Of Ventricular Arrhythmias

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

September 30, 2004

Conditions
Arrhythmia
Interventions
DRUG

Atorvastatin 80mg

Trial Locations (10)

Unknown

Pfizer Investigational Site, Aalst

Pfizer Investigational Site, Antwerp

Pfizer Investigational Site, Bruges

Pfizer Investigational Site, Edegem

Pfizer Investigational Site, Ghent

Pfizer Investigational Site, Hasselt

Pfizer Investigational Site, Leuven

Pfizer Investigational Site, Athens

Pfizer Investigational Site, Crete

Pfizer Investigational Site, RIO Patra

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00457340 - Atorvastatin For The Reduction Of Ventricular Arrhythmias | Biotech Hunter | Biotech Hunter